May 22, 2024

Summer Funding Announcement – 2024

WE-REACH is pleased to announce plans for an upcoming Summer 2024 Research Funding Announcement! Stay tuned for more information on Friday 5/24!

January 17, 2024

UM and UW Partner to Create SIHI-REACH, an NIH-Designated Entrepreneurial Hub for the PNW

(Seattle, WA)— The National Institutes of Health (NIH) has chosen the University of Montana’s L.S. Skaggs Institute of Health Innovation as the new Pacific Northwest location for one of five entrepreneurial hubs across the United States. Dubbed SIHI-REACH, this hub will support academic innovators across the WWAMI region in Washington, Wyoming, Alaska, Montana, and Idaho….

August 10, 2022

A Paradigm Shift in Medical Tape

It all began with a bad experience. Isn’t that the catalyst for most innovations? Professor Eric Seibel, a UW researcher in Mechanical Engineering and practical problem-solver, was by the bedside of his young son who had fallen out of a tree and ended up in Seattle Children’s Hospital with cracked ribs. During his treatment, Seibel’s…

July 12, 2022

WE-REACH Supports Institute for Protein Design Spinouts

WE-REACH is proud to support spinouts from the UW Institute for Protein Design (IPD) including Anindya Roy’s Lila Biologics, Stephanie Berger’s Mopac Bio, and George Ueda and James Lazarovits Tie2 super agonists project to treat acute respiratory distress syndrome and sepsis. For more information, see Charlotte Schubert’s latest article in Geekwire.

May 2, 2022

Roy Wins WE-REACH Go-To-Market Award for Novel Drug to Treat Idiopathic Pulmonary Fibrosis (IPF)

Dr. Anindya Roy

Seattle, WA (May 2, 2022)—The Washington Entrepreneurial Research Evaluation and Commercialization Hub (WE-REACH) is pleased to announce a product concept award for Dr. Anindya Roy and his team at the UW Medicine Institute for Protein Design, including Drs. Jake Kraft and Hua Bai. They are developing a novel binder protein in an aerosolized delivery system…

February 1, 2022

Healing Hands: WE-REACH Helps Fund Game-Changing Hand Injury Treatment, ReHeal

Serious hand and finger injuries provided the impetus for three individual innovators to connect, collaborate, and investigate over the past 10 years. The result is a promising prototype device called the ReHeal Glove, which will be pilot tested with patients in the next few months using a combination of funding and support from WE-REACH (the…

November 11, 2021

$14.9M Awarded to Lutz Lab’s COVID-19 Technology Company

Anavasi Diagnostics, a company recently founded out of Professor Barry Lutz’s lab at the University of Washington, announced it has been awarded $14.9 million from the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADxSM) initiative. The funding will accelerate the launch and broad market availability of the AscencioDx™ molecular diagnostic platform for the detection of RNA indicative…

WE-REACH support helps team pivot from academia to small business venture

Flipping the switch from professor to entrepreneur — where one endures intense pace and high-pressure stakes— is a daunting proposition. Having access to a team of experts and services through Washington Entrepreneurial Research Evaluation & Commercialization Hub (WE-REACH), a group dedicated to transforming novel breakthroughs into innovative products, can make a huge difference. Take Dr….

August 6, 2021

WE-REACH Fall Proposal Due Date Extended to August 9th

WE-REACH’s Fall proposal submission deadline has been extended to August 9th! A 2-page Declaration of Intent is due by 5:00pm on August 9th for proof of product concept projects in the biotech space (medical devices, therapeutics, and diagnostics). Projects are funded between $75-185k. Full applications are due October 4th. Learn More!  

June 7, 2021

Immediate funding opportunity for point-of-care COVID variant testing and more! Deadline June 28

COVID-19 Funding Opportunity RADx Tech II: Fast-Track Program to Advance U.S. COVID-19 Testing Capabilities  The National Institute of Biomedical Imaging and Bioengineering (NIBIB) is announcing today that its Point-of-Care Technology Research Network (POCTRN) is soliciting proposals to further advance SARS-CoV-2 testing technologies in order to fill specific unmet national needs. Unmet needs include but are not…

Next page